Product Alert: t:slim X2 Insulin Pump. Learn more
Australians living with Type 1 Diabetes can access subsidised Dexcom G6. Learn more
ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on amsldiabetes.com.au/resources before purchasing. Consult your healthcare professional to see if this product is right for you.
The pump that gets updated, not outdated. The simple-to-use t:slim X2 insulin pump has a slim and sleek design and packed with big features.
Easy, accurate§ and better health outcomes.1-5 Manage your diabetes with zero fingerpricks.* Stay on track to be your best with Dexcom G7 and Dexcom ONE+.
With over 20,000 Dexcom Warriors globally, Warriors are Dexcom CGM customers with inspiring stories who want to share their experiences with others – whether that be balancing their glucose levels whilst working the 9 to 5, competing in their chosen sport/profession at an elite level or perhaps progressing with their goals such as completing university degrees or adventurous treks. This program is supported by AMSL Diabetes.
Dexcom is a continuous glucose monitoring system indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated. The t:slim X2 insulin pump is portable insulin infusion pump, including sterile cartridge, that delivers insulin subcutaneously through a disposable infusion set.
‡ If your glucose alerts and readings from the Dexcom G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions; * This product is indicated for persons with diabetes mellitus age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated; † As compared to Dexcom G6 System; § Bolus delivery from the Tandem t:slim mobile app requires a compatible smartphone model and operating system, software version 7.8.1 onwards on the t:slim X2 insulin pump and additional training; || Smart device sold separately. To view a list of compatible devices, visit amsldiabetes.com.au/mobile-compatibility.
References: 1 Beck RW, et al. JAMA. 2017;317(4):371-378; 2 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374; 3 Martens T, et al. JAMA. 2021;325(22):2262-2272; 4 Laffel LM, et al. JAMA. 2020;323(23):2388-2396; 5 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7.
© 2025 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, Basal-IQ, Control-IQ, and t:slim X2 are registered trademarks or trademarks of Tandem Diabetes Care, Inc., in the United States and other countries. ©2025 Dexcom, Inc. All rights reserved. Dexcom, Dexcom G6, Dexcom G7, Dexcom ONE+ are registered trademarks of Dexcom, Inc. in the United States and other countries. Australasian Medical and Scientific Limited is a Dexcom company. MAT-6989
Login or register to access restricted resources